Merck & Co. reported solid Q4 2025 results, driven by oncology and new launches, while detailing a robust pipeline it believes can deliver over $70 billion in commercial potential by the mid-2030s, aiming to ensure growth past Keytruda's patent expiration.
The Southern-themed restaurant chain has issued internal guidelines requiring traveling staff to take meals primarily at company locations, a move that has sparked debate over corporate culture and employee autonomy.
The Walt Disney Company has unveiled its long-awaited succession plan, appointing Josh D'Amaro as Chief Executive Officer and Dana Walden as President and Chief Creative Officer, effective March 18.
JPMorgan Chase expands its Iowa footprint with a new Ames branch, anchoring its arrival with a seven-figure philanthropic package aimed at fueling small business innovation and resilience across the state.
The historic Swiss watchmaker Longines has opened a dedicated boutique on Amazon Luxury, marking its first direct-to-consumer partnership with the e-commerce giant and significantly expanding its digital retail footprint in the U.S. market.
After months of lackluster performance, Palantir Technologies stuns the market with record-breaking quarterly results and bullish forecasts, reasserting its position as a dominant force in the commercial AI sector.
Governor Josh Shapiro unveils a state framework to manage the rapid expansion of data centers, balancing economic opportunity with community and environmental concerns as the issue gains political traction.
Bloom Energy's solid-oxide fuel cell technology is emerging as a critical solution for powering the AI-driven data center expansion, driving record revenue and a staggering stock rally that continues into 2026.
Christian Dior's shares have faced sustained pressure, declining over 15% in the past month. While its P/E ratio suggests a premium to some peers, a discounted cash flow model indicates a potential 48% undervaluation, creating a complex picture for investors.
Target's shares have tumbled over 14% in the past year, lagging behind peers and raising questions about its valuation. A deep dive into cash flow and earnings multiples suggests the big-box retailer may be significantly undervalued, but the broader challenges facing the sector remain.
Vera Therapeutics elevates Matt Skelton to Chief Commercial Officer, signaling a strategic shift towards commercialization as its lead drug candidate, atacicept for IgA nephropathy, undergoes FDA Priority Review with a PDUFA date set for July 2026.
Investment firm Giverny Capital has established a significant, long-term position in Watsco, the leading U.S. HVAC distributor. The move underscores institutional confidence in the company's entrenched market position and its leverage to enduring trends in building climate control.
Bloom Energy secures a multi-billion dollar, multi-year agreement with American Electric Power, marking its largest commercial deal to date. The partnership promises a major rollout of Bloom's fuel cell technology but arrives as the company's stock faces intense scrutiny over its recent meteoric rise and long-term valuation.
CrowdStrike Holdings earns a prestigious customer recognition in Gartner's 2026 application security report while aggressively expanding its regional cloud infrastructure into the Middle East and Asia, presenting a complex picture of growth momentum against a backdrop of a premium stock valuation.
SolarEdge Technologies has initiated exports of its U.S.-manufactured residential inverters to key European markets, marking a strategic pivot to leverage domestic production for global growth. The move, coupled with a new 'single SKU' product design, aims to streamline operations and improve margins as the company navigates a competitive landscape.
The Southern-themed restaurant chain has quietly implemented a new travel policy requiring staff to eat primarily at company locations during business trips, while tightening reimbursement rules for alcohol and discretionary expenses.
New data reveals companies embracing structured flexibility are growing significantly faster and attracting deeper talent pools than their office-mandate rivals, reshaping the post-pandemic competitive landscape.
Visa and UnionPay International announce a strategic partnership to enable real-time, cross-border payments directly to debit cards in China, targeting one of the world's largest remittance corridors by 2026.
As 7-Eleven prepares for a pivotal North American IPO, the hunt for a new chief executive intensifies. The successor must navigate profitability challenges and steer the iconic convenience chain into its next era. Industry insiders are closely watching a mix of internal veterans and external contenders for the top job.
The FDA launches a new program to fast-track reviews for strategically important drug manufacturing facilities. In separate developments, AstraZeneca faces a setback for a lupus drug formulation, while Acadia Pharmaceuticals receives a negative signal from European regulators for its Rett syndrome therapy.
